Cosmetics
Warning Letters Related to Cosmetics
Matters described in FDA Warning Letters may have been subject to subsequent interaction between FDA and the recipient of the letter that may have changed the regulatory status of the issues discussed in the letter. If you wish to obtain available additional information on the current status of an issue in a particular Warning Letter on this Web site, please contact FDA or the recipient of the letter directly. Inquiries to FDA should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5600 Fishers Lane, Rockville, MD 20857. Instructions for submitting an FOI request are available online.
Warning Letters Address Drug Claims Made for Products Marketed as Cosmetics Updated October 31, 2012
Warning Letters Cite Cosmetics as Adulterated Due to Microbial Contamination Updated August 21, 2012
Warning Letters Highlight Differences Between Cosmetics and Medical Devices Updated April 28, 2011
Warning Letter Cites Brazilian Blowout for Safety and Labeling Violations August 22, 2011
Warning Letter to Procter and Gamble (Olay LLC) Cites Inadequate Manufacturing Conditions April 24, 2009
Warning Letter to Black Henna Ink, Inc. Cites Illegal Use of Color Additive August 14, 2006
Warning Letter to Parnell Pharmaceuticals, Inc. Cites Oral Moisturizer as Adulterated and Misbranded Medical Device July 10, 2006
Warning Letters Cite Cosmetics as Adulterated Due to Violative Use of Canthaxanthin April 5, 2005
